Cagrilintide | |
Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. It is mainly used for the treatment of type 2 diabetes. It can lower blood sugar and control blood sugar levels. CAS No.: 1415456-99-3 EC Number: 206-141-6 | |
| Target State: All States Target City : All Cities Last Update : Jul 25, 2025 5:13 AM Number of Views: 74 | Item Owner : Shelley Contact Email: Contact Phone: +4407419376761 |
| Friendly reminder: Click here to read some tips. | |